Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation - Wikidata - awgldk - TriplyDB

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation

http://www.wikidata.org/entity/Q34994425

about

Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study.T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity.Risk for metabolic diseases in normal weight individuals with visceral fat accumulation: a cross-sectional study in Japan Effect of High-fat Diet-induced Disorders on Rat with Endometrial Hyperplasia and Adiponectin System in Circulation and Uterus.Characteristics of sleep-wake cycle and sleep duration in Japanese type 2 diabetes patients with visceral fat accumulation.Dysregulated lipid storage and its relationship with insulin resistance and cardiovascular risk factors in non-obese Asian patients with type 2 diabetes.

P2860

Q36822591-8D2D6AAB-6CAB-47E3-85B2-AC0B4D75239E Q37593623-52499857-2352-4FE3-B293-B576D2E415F0 Q37598406-A458F563-1332-404E-9D8A-5F49A4D921E9 Q38658205-E42DBF53-2875-4F69-9CFE-2A715CD930B3 Q47765691-CE6FFCD0-3535-4213-971B-4DCBEED7406C Q50144392-6019596D-924F-45BE-99DA-DEC2F863CF62

P2860

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation

http://www.wikidata.org/entity/Q34994425

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Systemic arteriosclerosis and ...... with visceral fat accumulation

@ast

Systemic arteriosclerosis and ...... with visceral fat accumulation

@en

Systemic arteriosclerosis and ...... with visceral fat accumulation

@nl

type

label

Systemic arteriosclerosis and ...... with visceral fat accumulation

@ast

Systemic arteriosclerosis and ...... with visceral fat accumulation

@en

Systemic arteriosclerosis and ...... with visceral fat accumulation

@nl

prefLabel

Systemic arteriosclerosis and ...... with visceral fat accumulation

@ast

Systemic arteriosclerosis and ...... with visceral fat accumulation

@en

Systemic arteriosclerosis and ...... with visceral fat accumulation

@nl

P1433

Q34994425-4936EEB9-1FB5-422A-9CAC-DCA615AF8D6F

P1476

Q34994425-24CAB7BA-E148-462C-853F-287FCBC145F7

P2093

Q34994425-11E81E53-1E68-493E-8B96-EE77083B11A4

Q34994425-1C2C19B7-C93C-4056-82D7-D4C36FE88B14

Q34994425-1D758642-3C64-4314-B22E-999565213D84

Q34994425-2127712A-E128-49AF-B44C-6F1155754EF2

Q34994425-3588E01D-36B2-4464-BA1C-2111402495F3

Q34994425-415FD17D-9E10-4813-84FE-B0C01FF978A2

Q34994425-42458C7F-5FC5-48BC-A845-83E1D1A164F3

Q34994425-6A3A4AFC-D0D8-4905-90CA-C5B89F26ADD3

Q34994425-8FA17483-9DA5-4F3D-B80A-CB274ECFB522

Q34994425-99F487D8-947A-4794-B2C3-407012F6D278

P2860

Q34994425-0A438CB8-ACA5-45E4-9BF5-33FADFEBC5D6

Q34994425-0C57A3C8-8679-4361-AA05-94F23DE7EFDE

Q34994425-0E4EE2DB-1570-442B-B521-B15F85FDDB79

Q34994425-0EC672AD-BEF5-408B-97C4-FE1C145A1D1C

Q34994425-10C17D92-EB8F-4978-A9C7-0BE688AFB647

Q34994425-1787BE90-669C-4076-89C1-CDFC2206B465

Q34994425-1918C55D-6247-4A56-B09B-33AF9A2F8A58

Q34994425-23D4404F-E866-4A5A-BC14-64F31EAF8D02

Q34994425-2B566892-0B15-4827-A565-7F87FD9ACCCA

Q34994425-2F3BB9FF-FC27-4777-B8D1-124DE2A20498

P2888

Q34994425-0C71C324-B282-4D8E-A304-13D17141F1FD

P304

Q34994425-0894623A-D75D-40D3-933D-31384BC7034F

P31

Q34994425-98F24FC0-354F-40D9-8115-6965A7E334D6

P356

Q34994425-F37DC239-FFFE-4218-A108-3C212740B9DC

P407

Q34994425-876DB7A8-13E1-4343-98D3-B484C8AC5845

P478

Q34994425-80415FAA-954E-42E4-98CA-7E8AA9F6210C

P577

Q34994425-A0305A72-8F4E-457A-8F32-26F4D9CB3BAC

P5875

Q34994425-C7E24AEC-9A02-4117-B592-BE1D8830DEFA

P6179

Q34994425-E704C58E-B558-4485-89B4-D3E044EC0DB5

P698

Q34994425-34E389AC-50FC-47A8-9944-97CCC3DA0F53

P932

Q34994425-45EC32D2-E896-488A-8A8E-6456CF2260B7

P356

S12933-015-0174-7

P1433

Cardiovascular Diabetology

P1476

Systemic arteriosclerosis and ...... with visceral fat accumulation

@en

P2093

Akihisa Imagawa

http://www.w3.org/2001/XMLSchema#string

Ayumu Hirata

http://www.w3.org/2001/XMLSchema#string

Hirofumi Nagao

http://www.w3.org/2001/XMLSchema#string

Hitoshi Nishizawa

http://www.w3.org/2001/XMLSchema#string

Iichiro Shimomura

http://www.w3.org/2001/XMLSchema#string

Junji Kozawa

http://www.w3.org/2001/XMLSchema#string

Kana Inoue

http://www.w3.org/2001/XMLSchema#string

Masaya Yamaoka

http://www.w3.org/2001/XMLSchema#string

Norikazu Maeda

http://www.w3.org/2001/XMLSchema#string

Shiro Fukuda

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Epidemic obesity and type 2 diabetes in Asia

The Physiology of Glucagon-like Peptide 1

Global estimates of the prevalence of diabetes for 2010 and 2030

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes.

P2888

s12933-015-0174-7

P304

8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-015-0174-7

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270907734

http://www.w3.org/2001/XMLSchema#string

P6179

1015611998

http://www.w3.org/2001/XMLSchema#string

P698

25592402

http://www.w3.org/2001/XMLSchema#string

P932

4301666

http://www.w3.org/2001/XMLSchema#string